News
- Author:
- Mary Ann Moon
Publish date: April 10, 2013
Major finding: Overall survival was 97% in adults treated with DA-EPOCH-R, and event-free survival was 93%.Data source: A phase II, prospective cli...
News
- Author:
- Mary Ann Moon
Publish date: April 10, 2013
Major finding: None of the 114 patients who participated in the Death with Dignity (assisted-suicide) program during a 2-year period, nor their fa...
News
- Author:
- Mary Ann Moon
Publish date: April 9, 2013
Major finding: The overall diabetes incidence decreased by 53% during and immediately after the economic crisis, then rebounded, rising by 140% du...
News
- Author:
- Mary Ann Moon
Publish date: April 8, 2013
Major Finding: Despite the success of the cardiac procedures, a significantly higher proportion of radiation-exposed patients died during follow-u...
News
- Author:
- Mary Ann Moon
Publish date: April 8, 2013
News
- Author:
- Mary Ann Moon
Publish date: April 3, 2013
Major finding: Median survival was 5.1 years with intermittent androgen-deprivation therapy and 5.8 years with continuous androgen-deprivation the...
News
- Author:
- Mary Ann Moon
Publish date: April 2, 2013
Major finding: Study subjects were 2.4 times more likely to experience a 50% pain reduction while taking duloxetine than while taking placebo.Data...
News
- Author:
- Mary Ann Moon
Publish date: April 2, 2013
Major Finding: Adults with serious mental illnesses who participated in a behavioral weight-loss intervention lost a mean of 1.8 kg at 6 months an...
News
- Author:
- Mary Ann Moon
Publish date: April 1, 2013
Major Finding: All the study subjects showed significant improvement in cognitive function after 12 weeks, regardless of whether they had particip...
News
- Author:
- Mary Ann Moon
Publish date: April 1, 2013
Major Finding: New use of systemic glucocorticoids was associated with the highest risk for VTE, with an estimated incidence rate ratio of 3.06, c...
News
- Author:
- Mary Ann Moon
Publish date: March 27, 2013
Major Finding: Miravirsen cut HCV RNA levels 1.2 log at the 3-mg/kg dose, 2.9 log at the 5-mg/kg dose, and 3.0 log at the 7-mg/kg dose.Data Source...
News
- Author:
- Mary Ann Moon
Publish date: March 26, 2013
Major Finding: Ganetespib was 30 times more potent in vitro than crizotinib against ALK-driven NSCLC.Data Source: Cell culture and response in xen...
News
- Author:
- Mary Ann Moon
Publish date: March 26, 2013
Major Finding: The risk of AAA rupture in men would be less than 1% if surveillance intervals were extended to 3 years for AAAs measuring 3.0-3.9 ...
News
- Author:
- Mary Ann Moon
Publish date: March 20, 2013
Major Finding: By the time U.S.
News
- Author:
- Mary Ann Moon
Publish date: March 20, 2013
Major finding: In the PC Trial, the primary endpoint, a composite of death, nonfatal stroke, TIA, or peripheral embolism, occurred in 7 patients (...
